The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes and prognostic factors for immune checkpoint inhibitors in dMMR/MSI-H metastatic colorectal cancer (mCRC).
 
Thiago Miranda
No Relationships to Disclose
 
Chuang Ching
No Relationships to Disclose
 
Jonathan Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; BMS GmbH & Co. KG; GlaxoSmithKline; Ipsen; Merck; Pfizer; Sanofi
Research Funding - Personalis
 
Renata Peixoto
Honoraria - AstraZeneca; SERVIER
Consulting or Advisory Role - AstraZeneca; Taiho Oncology
Travel, Accommodations, Expenses - AstraZeneca; UnitedHealthcare
 
Joao Paulo Solar Vasconcelos
Honoraria - Incyte Biosciences Canada Corporation; Pfizer
Consulting or Advisory Role - Astellas Pharma; Ipsen
 
Howard Lim
Honoraria - Amgen; Astellas Pharma; AstraZeneca Canada; BeiGene; BMS Canada; Dicephera Pharmaceuticals, Inc.; eisai; Ipsen; Merck; Roche Canada; Taiho Pharmaceutical; Takeda; Varian Medical Systems
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Eisai; Taiho Oncology
 
Sharlene Gill
Honoraria - Eisai; Roche Canada
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb Canada; Eisai; Ipsen; Merck; Pfizer; Roche Canada
Research Funding - Amgen (Inst); Pfizer (Inst)